A pH-responsive polymeric nanovaccine with efficient endosomal escape and potent antitumor immunity for cancer treatment
Source abstract
Abstract
The efficacy of cancer vaccines is often limited by poor cytosolic antigen delivery. Here, we report a pH-responsive copolymer nanovaccine that remains inert under physiological conditions yet undergoes acid-triggered activation within endosomes. This activation induces membrane disruption and rapid antigen release, enhances endosomal escape, thereby enabling efficient cytosolic antigen delivery. These result in greatly enhanced antigen cross-presentation and dendritic cell maturation, which together drive strong activation and effector differentiation of antigen-specific CD8⁺ T cells. Through this approach the nanovaccine elicited strong cellular immunity and achieved marked tumor suppression with favorable biocompatibility across multiple murine tumor models. This work collectively provides a generalized, yet flexible strategy that overcomes the endosomal escape bottleneck and improves cytosolic antigen delivery for next-generation cancer vaccines. STATEMENT OF SIGNIFICANCE: (i) a mechanistically supported approach to improve endosomal escape for cytosolic antigen delivery; (ii) a polymer design framework that can be adapted to antigen delivery applications; (iii) in vivo evidence linking nanoscale material behavior to systemic antitumor immune responses.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Research and Treatments · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Recent advances in therapeutic cancer vaccines10.1038/s41568-025-00820-z ↗
2. Therapeutic cancer vaccines10.1038/s41568-021-00346-0 ↗
3. Therapeutic cancer vaccines: advancements, challenges and prospects10.1038/s41392-023-01674-3 ↗
4. CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours10.1038/s41586-023-06199-x ↗
5. Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing10.1016/j.immuni.2022.04.016 ↗
6. Biomaterials facilitating dendritic cell-mediated cancer immunotherapy10.1002/advs.202301339 ↗
7. Glucosylated nanovaccines for dendritic cell-targeted antigen delivery and amplified cancer immunotherapy10.1021/acsnano.4c09053 ↗
8. Dendritic cell-targeted tumor antigen delivery by glucosylated lipid nanoparticles for precision tumor immunotherapy10.1016/j.jconrel.2026.114671 ↗
9. Endosomal escape: a bottleneck for LNP-mediated therapeutics10.1073/pnas.2307800120 ↗
10. Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion10.1038/s41467-025-61230-1 ↗
11. DNA-inspired nanomaterials for enhanced endosomal escape10.1073/pnas.2104511118 ↗
12. In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate10.1016/j.biomaterials.2019.119296 ↗
13. Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers10.1073/pnas.2220787120 ↗
14. Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo10.1038/s41467-021-25448-z ↗
15. In vivo peptide-based delivery of a gene-modifying enzyme into cells of the central nervous system10.1126/sciadv.abo2954 ↗
16. Melittin can permeabilize membranes via large transient pores10.1038/s41467-024-51691-1 ↗
17. Influence of the spatial distribution of cationic functional groups at nanoparticle surfaces on bacterial viability and membrane interactions10.1021/jacs.0c02737 ↗
18. Ultrasonic particles: an approach for targeted gene delivery10.1016/j.addr.2021.113998 ↗
19. Dendritic hydrogels induce immune modulation in Human keratinocytes and effectively eradicate bacterial pathogens10.1021/jacs.1c07492 ↗
20. Antimicrobial peptides increase line tension in raft-forming lipid membranes10.1021/jacs.4c05377 ↗
21. Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain10.1016/j.biomaterials.2021.121340 ↗
22. Machine learning for antimicrobial peptide identification and design10.1038/s44222-024-00152-x ↗
23. On-the-fly microfluidic control of giant vesicle compositions validated by DNA surface charge sensors10.1021/acsnano.4c16289 ↗
24. De novo design of selective membrane-active peptides by enzymatic control of their conformational bias on the cell surface10.1002/anie.201902470 ↗
25. Rational design of lipid-based vectors for advanced therapeutic vaccines10.3390/vaccines12060603 ↗
26. Potent amphiphilic poly (Amino Acid) nanoadjuvant delivers biomineralized ovalbumin for photothermal-augmented immunotherapy10.1021/acsnano.4c10688 ↗
27. pH-responsive nano-vaccine combined with anti-PD-1 antibodies for enhanced immunotherapy of breast cancer10.7150/thno.107200 ↗
28. pH and ROS responsiveness of polymersome nanovaccines for antigen and adjuvant codelivery: an In vitro and In vivo comparison10.1021/acs.biomac.3c01235 ↗
29. Dual stimuli-responsive dendronized prodrug derived from poly (oligo - (ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect10.1016/j.actbio.2022.02.033 ↗
30. Polycarbonate-based ultra-pH sensitive nanoparticles improve therapeutic window10.1038/s41467-020-19651-7 ↗
31. Elucidation of protonation cooperativity of a STING-activating polymer10.1002/adma.202305255 ↗
32. Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes10.1016/j.addr.2016.08.014 ↗
33. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis10.1038/s41565-019-0600-1 ↗
34. Gal8 Visualization of endosome disruption predicts carrier-mediated biologic drug intracellular bioavailability
35. Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement10.1021/acsnano.1c04996 ↗
36. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
37. Dendrimer space concept for innovative nanomedicine: a futuristic vision for medicinal chemistry10.1016/j.progpolymsci.2013.03.003 ↗
38. A CpG 1018S/QS-21-adjuvanted HBsAg therapeutic vaccine as a novel strategy against HBV10.3390/vaccines13101014 ↗
39. Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy10.1016/j.addr.2020.10.004 ↗
40. Late-stage functionalization of living organisms: rethinking selectivity in biology10.1021/acs.chemrev.3c00579 ↗